Table 5 Patients’ distribution according to clinical symptoms and to mechanism of hypersensitivity reactions during anaesthesia
From: Identification of risk factors of severe hypersensitivity reactions in general anaesthesia
Symptoms group | IgE-mediated hypersensitivity | No. of patients | P value | |
|---|---|---|---|---|
Mucocutaneous | 0 | 1 | Â | Â |
0 | 35 (25.36%) | 18 (32.72%) | 53 | 0.372 |
1 | 103 (74.63%) | 37 (67.27%) | 140 | |
Cardiovascular | 0 | 1 | Â | Â |
0 | 124 (89.86%) | 40 (72.73%) | 164 | 0.006 |
1 | 14 (10.14%) | 15 (27.27%) | 29 | |
Bronchospasm | 0 | 1 | Â | Â |
0 | 97 (70.29%) | 34 (61.82%) | 131 | 0.010 |
1 | 41 (29.71%) | 21 (38.18%) | 62 | |
No. of patients | 138 | 55 | 193 | Â |